RU94037232A - Пептиды с органозащитной активностью, способ их получения и их применение - Google Patents

Пептиды с органозащитной активностью, способ их получения и их применение

Info

Publication number
RU94037232A
RU94037232A RU94037232/04A RU94037232A RU94037232A RU 94037232 A RU94037232 A RU 94037232A RU 94037232/04 A RU94037232/04 A RU 94037232/04A RU 94037232 A RU94037232 A RU 94037232A RU 94037232 A RU94037232 A RU 94037232A
Authority
RU
Russia
Prior art keywords
peptides
synthesis
protective activity
peptides showing
showing organ
Prior art date
Application number
RU94037232/04A
Other languages
English (en)
Other versions
RU2116311C1 (ru
Inventor
Сикирич Предраг
Hr]
Петек Мариян
Зайверт Свен
Грабаревич Желько
Ротквич Иво
Дувняк Марко
Туркович Бранко
Мисе Степан
Суханек Эрнест
Мильднер Борис
Удовичич Иван
Original Assignee
Сикирич Предраг
Hr]
Петек Мариян
Зайверт Свен
Грабаревич Желько
Ротквич Иво
Дувняк Марко
Туркович Бранко
Мисе Степан
Суханек Эрнест
Мильднер Борис
Удовичич Иван
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сикирич Предраг, Hr], Петек Мариян, Зайверт Свен, Грабаревич Желько, Ротквич Иво, Дувняк Марко, Туркович Бранко, Мисе Степан, Суханек Эрнест, Мильднер Борис, Удовичич Иван filed Critical Сикирич Предраг
Publication of RU94037232A publication Critical patent/RU94037232A/ru
Application granted granted Critical
Publication of RU2116311C1 publication Critical patent/RU2116311C1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Пептиды с органозащитной активностью только с 8 - 15 аминокислотными остатками в цепи и молекулярной массой 900 - 1600, обладающие биологическим действием природного соединения, защищающего организм (ВРС), но с повышенной селективностью, способ получения таких пептидов и применение пептидов в качестве лекарственного препарата.

Claims (1)

  1. Пептиды с органозащитной активностью только с 8 - 15 аминокислотными остатками в цепи и молекулярной массой 900 - 1600, обладающие биологическим действием природного соединения, защищающего организм (ВРС), но с повышенной селективностью, способ получения таких пептидов и применение пептидов в качестве лекарственного препарата.
RU94037232A 1992-11-16 1993-11-16 Пептиды, обладающие органозащитной активностью, фармакологически активная композиция RU2116311C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR381-03/92-03/931 1992-11-16
HR921283 1992-11-16

Publications (2)

Publication Number Publication Date
RU94037232A true RU94037232A (ru) 1996-06-20
RU2116311C1 RU2116311C1 (ru) 1998-07-27

Family

ID=10945833

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94037232A RU2116311C1 (ru) 1992-11-16 1993-11-16 Пептиды, обладающие органозащитной активностью, фармакологически активная композиция

Country Status (17)

Country Link
EP (1) EP0624164B1 (ru)
JP (1) JP2812803B2 (ru)
AT (1) ATE163131T1 (ru)
AU (1) AU5624994A (ru)
BG (1) BG61697B1 (ru)
CA (1) CA2127553C (ru)
CZ (1) CZ285155B6 (ru)
DE (1) DE69316974T2 (ru)
ES (1) ES2114170T3 (ru)
GR (1) GR3026478T3 (ru)
HU (3) HUT66303A (ru)
PL (1) PL304666A1 (ru)
RO (1) RO115733B1 (ru)
RU (1) RU2116311C1 (ru)
SI (1) SI9300595B (ru)
SK (1) SK279227B6 (ru)
WO (1) WO1994011394A2 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199902866T2 (xx) 1997-05-23 2000-02-21 Sikiric Predrag Organo- koruyucu aktiviteye sahip yeni BPC peptid tuzlar�, haz�rlanmalar� ve terapide kullan�lmalar� i�in prosesler.
SI24318A (sl) * 2013-03-13 2014-09-30 Diagen D.O.O. Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU176089A (sh) * 1989-09-12 1992-09-07 Sikirić, Predrag Postupak za pripremu supstancije bpc i supstancija bpc
ATE152734T1 (de) * 1992-05-30 1997-05-15 Sikiric Predrag Bpc-peptide, deren herstellung und verwendung

Also Published As

Publication number Publication date
HUT67982A (en) 1995-05-29
SK279227B6 (sk) 1998-08-05
ATE163131T1 (de) 1998-02-15
SK85794A3 (en) 1995-01-12
DE69316974D1 (de) 1998-03-19
EP0624164B1 (en) 1998-02-11
CZ162294A3 (en) 1995-02-15
CZ285155B6 (cs) 1999-05-12
CA2127553C (en) 2003-01-28
HUT66303A (en) 1994-11-28
HU211260A9 (en) 1995-11-28
DE69316974T2 (de) 1998-07-16
WO1994011394A3 (en) 1994-09-15
RO115733B1 (ro) 2000-05-30
SI9300595A (en) 1994-09-30
AU5624994A (en) 1994-06-08
HU9401952D0 (en) 1994-09-28
EP0624164A1 (en) 1994-11-17
SI9300595B (sl) 2003-04-30
JP2812803B2 (ja) 1998-10-22
JPH07507568A (ja) 1995-08-24
CA2127553A1 (en) 1994-05-26
WO1994011394A2 (en) 1994-05-26
RU2116311C1 (ru) 1998-07-27
HU9303247D0 (en) 1994-03-28
GR3026478T3 (en) 1998-06-30
PL304666A1 (en) 1995-01-09
ES2114170T3 (es) 1998-05-16
BG61697B1 (bg) 1998-03-31
BG98907A (bg) 1995-05-31

Similar Documents

Publication Publication Date Title
CA2203694A1 (en) Cancer inhibitory peptides
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
RU94026283A (ru) Фармацевтическое соединение
DE69428040D1 (de) Orale darreichungsform
RU95106651A (ru) Аналоги дзе-тур динорфина и способ лечения толерантных состояний у пациента
RU97121820A (ru) Применение по меньшей мере одного пептида в косметической композиции или для получения лекарственного средства
JPH0364514B2 (ru)
KR910007858A (ko) 초기-촉진 및 향상된 진통제로서의 s(+)-이부프로펜-l-아미노산 및 s(+)-이부프로펜-d-아미노산
JPH02250895A (ja) 神経調節ペプチド
US5767087A (en) Pharmaceutical preparation for the therapy of immune deficiency conditions
IL137820A (en) Pharmaceutical composition for topical administration comprising an analgesic peptide
RU94037232A (ru) Пептиды с органозащитной активностью, способ их получения и их применение
DE69534024D1 (de) Peptide und pharmazeutische zusammensetzungen, die diese enthalten
FR2569111B1 (fr) Nouveaux medicaments contenant des tripeptides
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
RU2120298C1 (ru) Иммуностимулятор и препарат на его основе
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
BE905974A (fr) Conjugue de l'alpha-melanotropine avec la p-l-sarcolysine.
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
DE69420574D1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen
FR2694938B1 (fr) Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
JPS649938A (en) Oral ingestive composition
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
US6136788A (en) Pharmaceutical preparation for the therapy of immune deficiency conditions

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20111117